SWOT Analysis for Jubilant Pharmova Ltd.

Add SWOT widget to your site/app

Positive Breakout First Resistance ( LTP > R1)
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Mid-range Performer (DVM)
Growth Stars: Strongest Annual EPS Performers
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Companies with reducing Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
High Volume, High Gain
Top Gainers
High Volume, High Gain
Volume Shockers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter

Positive Breakout First Resistance ( LTP > R1)

Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Consistent Highest Return Stocks over Five Years

Mid-range Performer (DVM)

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Companies with reducing Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

High Volume, High Gain

Top Gainers

High Volume, High Gain

Volume Shockers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding
Companies with growing costs YoY for long term projects
Promoter holding decreased by more than -2% QoQ
Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)
Negative profit growth, promoters decreasing shareholding QoQ
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
RSI indicating price weakness
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Promoter decreasing their shareholding

Companies with growing costs YoY for long term projects

Promoter holding decreased by more than -2% QoQ

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)

Negative profit growth, promoters decreasing shareholding QoQ

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

RSI indicating price weakness

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Sells by Superstar Investors

Sells by Superstar Investors

High Piotroski Score - Companies with strong financials
Stocks with improving cash flow, with good durability
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)

High Piotroski Score - Companies with strong financials

Stocks with improving cash flow, with good durability

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)

Jubilant Pharmova Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Jubilant Pharmova Ltd. has 27 Strengths, 9 Weaknesses, 5 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential